Social Cognition in Pediatric Multiple Sclerosis (MS) (S33.006)

CONCLUSIONS: Findings suggest that over short time frames, stable or even improved performances on measures of cognitive ability can occur in pediatric MS. Rather than leading to decline, pediatric MS may instead adversely affect cognitive functioning by interfering with expected age-appropriate gains.Study Supported by: The Lourie Foundation, Inc., National Multiple Sclerosis Society (PP2106), National Multiple Sclerosis Society (10020073405), NIH R01N5071463, and the Slomo and Cindy Silvian Foundation.Disclosure: Dr. Charvet has received personal compensation for activities with Biogen Idec as a consultant. Dr. Charvet holds stock and/or stock options in Johnson & Johnson. Dr. Cleary has nothing to disclose. Dr. Vazquez has nothing to disclose. Dr. Koznesoff has nothing to disclose. Dr. Bartolotta has nothing to disclose. Dr. Benhamroun has nothing to disclose. Dr. Krupp has received personal compensation for activities with Teva Neurosciences, Biogen Idec, EMD Serono, Betaseron/Bayer Healthcare Pharmaceuticals, Guidepoint Consultants, and Novartis. Dr. Krupp has received royalty payments from Genzyme Corporation, Bristol-Myers Squibb Company, Biogen Idec, and Johnson & Johnson. Dr. Krupp has received research support from EMD Serono and Biogen Idec.
Source: Neurology - Category: Neurology Authors: Tags: Cognition Fatigue in Multiple Sclerosis Source Type: research